Prospecto: information for the user
NITROFIX 10 mg transdermal patches EFG
Nitroglycerin
Read this prospect carefully before starting to use this medication, as it contains important information for you.
1. What is NITROFIX 10 mg and how it is used
2. What you need to know before starting to take NITROFIX 10 mg
3. How to use NITROFIX 10 mg
4. Possible adverse effects
5. Storage of NITROFIX 10 mg
6. Contents of the package and additional information
NITROFIX 10 mg patchesare transdermal systems consisting of a thin, transparent low-density polyethylene film, covered by an adhesive matrix containing nitroglycerin. The matrix controls the release rate of the active ingredient. The patch is covered by a protective polyester film that is removed and discarded before use.
NITROFIX 10 mgis indicated for the prevention of angina pectoris on exertion and at rest, associated with coronary insufficiency.
Do not use NITROFIX 10mg
Be especially careful with NITROFIX 10mg
NITROFIX 10mg should be used under strict medical supervision in cases of myocardial infarction or congestive heart failure. It is recommended to exercise extreme caution when using NITROFIX 10mg in patients with hypoxemia or ventilation perfusion imbalance.
NITROFIX 10mg is not indicated for the treatment of acute angina attacks. In this case, your doctor will prescribe rapid-acting nitroderivatives by sublingual route.
If you are going to discontinue treatment, the dose and frequency of application of the NITROFIX 10mg patch should be gradually reduced over a period of 4-6 weeks to avoid withdrawal reactions of this type of vasodilator medication.
This medication may produce postural hypotension, especially in anxious patients, so avoid sudden changes in posture.
It is recommended to remove the patch before cardioversion or defibrillation.
Acclimatization to the preparation or to other nitroderivatives is possible. For this reason, your doctor may recommend applying NITROFIX 10mg daily with a patch-free interval of 8 to 12 hours to maintain low plasma levels.
Nitroglycerin may interfere with the measurement of certain clinical analyses (catecholamines and vanillylmandelic acid in urine, increasing their excretion).
Inform your doctor immediately if any of the following situations occur while using NITROFIX 10mg. Your doctor will decide if it is necessary to discontinue treatment with NITROFIX 10mg.
Use of other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.
It is advisable for your doctor to know if you are being treated with other medications, as they may potentiate the blood pressure-lowering effect of NITROFIX 10mg (calcium antagonists, beta-blockers, diuretics, antihypertensives, tricyclic antidepressants, major tranquilizers, and dihydroergotamine).
The administration of other vasodilators should be done with caution, in order to avoid the addition of effects.
The possibility of the ingestion of acetylsalicylic acid and non-steroidal anti-inflammatory substances decreasing the therapeutic response to NITROFIX 10mg cannot be excluded.
The action of this medication on the heart may be altered if used simultaneously with preparations containing sildenafil for penile erection (see contraindications).
The use of topical application products, especially if prolonged, may cause sensitization phenomena. In this case, treatment should be suspended, and appropriate therapeutic measures should be taken.
Use of NITROFIX 10mg with food and beverages
Excessive alcohol consumption should be avoided.
Pregnancy and lactation
Consult your doctor or pharmacist before using any medication.
NITROFIX 10mg should be used with caution during pregnancy and lactation. In these circumstances, the product is only suitable in cases of necessity and under direct medical control. If you are pregnant, notify your doctor immediately if you are regularly using this medication.
Use in children:The safety and efficacy in children under 18 years have not been established. Therefore, its use is not recommended.
Use in the elderly:Geriatric patients are usually more sensitive to the hypotensive effects.
Driving and operating machinery
Due to the potential for many side effects (dizziness, hypotension, etc...) to decrease reaction time, maximum precautions should be taken with driving or operating machinery at the beginning of treatment.
Follow exactly the administration instructions forNITROFIX10 mg as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.
The response to nitroderivatives varies from individual to individual and should be prescribed in each case the minimum effective dose. Since the amount of nitroglycerin released by the NITROFIX10 mg patch is constant, the administered dose depends solely on the area of contact of the patch.
The normal dose is to start treatment with a NITROFIX5 mg patch per day. If necessary, and based on demonstrated tolerance, treatment can be increased to a NITROFIX10 mg or even NITROFIX15 mg patch per day.
The application can be for a continuous period of 24 hours, or intermittently, incorporating an interval without a patch of8 to12 hours (usually at night).
INSTRUCTIONS FORCORRECT ADMINISTRATION
Each NITROFIX10 mg patch is contained in a small protective bag sealed. The adhesive area is covered by a protective film, which must be removed just before application to the skin.
Apply the NITROFIX10 mg patch to the skin on a clean, dry, healthy (without residue) and relatively hairless area.
The correct application procedure is as follows:
1.- Open the bag, tearing it along the mark and remove the patch from its interior.
2.- Gently fold the patch with the dotted marks facing towards you, pull the tab and discard the protective film.
3.- Apply the adhesive surface to the upper arm or chest. Carefully separate the other dotted part from the protective film.
4.- Press the patch firmly to ensure good placement.
Remove the NITROFIX10 mg patch at 24 hours, unless otherwise recommended by your doctor. NITROFIX10 mg patches are disposable. Keep them out of the reach of children.
Apply a new NITROFIX10 mg patch following the method described. This new patch should be applied to a different area from the previous one, for example, on the opposite side of the chest.
Do not apply the system to the same area for consecutive days. The NITROFIX10 mg patch adheres easily to the skin and does not detach with bathing, showering, or physical exercise.
If you use more NITROFIX10 mg than you should
High doses of nitroglycerin may, in some cases, cause a rapid drop in blood pressure and lead to shock, tachycardia, methemoglobinemia, cyanosis, coma, and seizures. Due to the controlled release of nitroglycerin with NITROFIX10 mg, the risk of overdose is very rare. Any decrease in blood pressure and collapse symptoms can be treated by elevating the lower extremities. Severe methemoglobinemia can be treated with a methylene blue or thionine injection.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone: (91) 562 04 20.
If you forgot to use NITROFIX10 mg
Do not take a double dose to compensate for the missed doses. Ensure you complete the treatment cycle.
If you interrupt treatment with NITROFIX10 mg
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Like all medications,NITROFIX10 mgmay cause adverse effects, although not everyone will experience them.
The tolerance to nitroglycerin is generally good. Headache is the most common side effect, especially when high doses are used. This side effect is usually counteracted with common pain relievers, although in particularly intense cases it may be necessary to reduce the dose or discontinue treatment.
Other possible side effects that may occur, especially at the beginning of treatment, are: arterial hypotension (especially postural), weakness, tachycardia, dizziness, palpitations, hot flashes, dizziness, nausea, vomiting, and dermatitis. Except for dermatitis, all of these are attributable to the pharmacological action of nitroglycerin. The doctor should be immediately informed of side effects and have the opportunity to suspend treatment with NITROFIX10 mg, at least temporarily.
The local tolerance is also generally good. Occasionally, it presents, and always in relation to the level of application, itching, stinging, and mild redness reactions. However, these effects usually disappear a few hours after removing the patch without the need to take any other measures.
If you consider that any of the adverse effects you are experiencing is severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
No requires special conditions for conservation
Keep out of reach and sight of children.
Do not useNITROFIX10 mg after the expiration date that appears on the package or case, after “CAD”. The expiration date is the last day of the month indicated.
Do not use NITROFIX10 mg if you observe visible signs of deterioration.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medicines that you do not need.This will help protect the environment..
Composition of NITROFIX 10 mg
The active ingredient is Nitroglycerin 53 mg releasing 10 mg/24 hours.
The other components are, DURO-tak 872852, sorbitan monooleate, propylene glycol, low-density polyethylene oval film, transparent polyester film.
Appearance of NITROFIX 10 mg and contents of the packaging
NITROFIX are transparent transdermal patches with a surface area of 13.3 cm² and are presented in packaging of 7 or 30 transdermal patches.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
ARAFARMA GROUP, S.A.
C/ Fray Gabriel de San Antonio, 6-10
Pol. Ind. del Henares
19180 Marchamalo (Guadalajara). Spain.
Responsible for manufacturing:
IBSA FARMACEUTICI ITALIA SRL
Strada Statale Nº 11, Padana Superiore, km 160
20051-Cassina de’ Pecchi (MI)
Italy
Or
ALTERGON ITALIA SRL
Zona Industriale ASI,
Morra de Sanctis - 83040 (Av)
Italy
This leaflet was approved in April 2019.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.